2940
A. Srikrishna et al. / Tetrahedron Letters 45 (2004) 2939–2942
(Scheme 2). Thus, sonochemically accelerated reaction
of the enone 3t with pent-4-enyl bromide and lithium
under Barbier conditions followed by oxidation of the
resultant tertiary alcohol 4 with pyridinium chloro-
chromate (PCC) and silica gel furnished the enone 5.
Reductive allylation of the enone 5 with lithium in liquid
established on the basis of the spectral data and litera-
ture precedents.7 Contrary to our expectations,8 the
RCM reaction of the compound 6 was found to be very
efficient even with the first generation GrubbsÕ catalyst
7a. Treatment of the dienone 6 with 10 mol % of the
catalyst 7a in 0.005 M methylene chloride solution at
room temperature for 2 h resulted in the efficient closure
of the eight-membered ring to give the bicyclic com-
pound 9 in near quantitative yield. Compound 9 rep-
resents a typical BC-ring system of taxane containing
both the C-19 and C-20 methyl groups, with the natural
configuration at the C-3 and C-8 positions and a trans-
BC ring junction.
ammonia and allyl bromide generated the RCM pre-
24
D
selective manner. The stereochemistry of
cursor 6, ½aꢀ ꢁ10.0 (c 6.6, CHCl3), in a highly stereo-
6 was
O
b
c
HO
O
a
After successfully generating the BC-ring system 9 via
the first option, we then investigated the second option,
Scheme 3. Since the isopropenyl group is a masked
ketone, it was conceived that generation of the two 6,6-
dialkylated carvones 10a and 10b would give access to
both enantiomeric forms of BC-taxanes. Generation of
the kinetic enolate of 6-methylcarvone 3 with LDA and
treatment with allyl bromide generated the alkylated
product (4S,5S)-10a. Reversal of the alkylation
sequence, namely first allylation of carvone followed by
methylation, gave the compound (4R,5S)-10b.9 Cou-
pling of the dialkylated compounds 10a,b with pent-4-
R
2 R = H
3t R = Me
4
5
O
O
d
e
H
9
H
6
Scheme 2. Reagents and conditions: (a) (i) LDA, THF, ꢁ70 °C; MeI,
!rt, 12 h, 95%; (ii) crystallisation from hexane; (b) Li,
CH2@CH(CH2)3Br, THF, ))), 15 °C ! rt, 0.5 h; (c) PCC, silica gel,
CH2Cl2, rt, 4 h; 85% from 3t; (d) Li, liquid NH3, THF, ꢁ33 °C, allyl
bromide, 80%; (e) 10 mol % 7a, CH2Cl2, rt, 2 h, >95%.
All compounds exhibited spectral data consistent with their structures. Yields (unoptimised) refer to isolated and chromatographically pure
22
compounds. Selected spectral data for 9: Mp: 86–88 °C. ½aꢀ ꢁ4.5 (c 1.8, CHCl3). IR (neat): mmax/cmꢁ1 1708. 1H NMR (300 MHz, CDCl3þCCl4):
D
d 5.73 (1H, ddd, J ¼ 10:5, 7.8, 7.8 Hz), 5.59 (1H, ddd, J ¼ 10:5, 10.5, 6.6 Hz), 4.74 (2H, s), 2.64 (1H, t, J ¼ 13:5 Hz), 2.45 (1H, dd, J ¼ 12:9, 6.6 Hz),
2.20–1.90 (5H, m), 1.80–1.50 (5H, m), 1.67 (3H, s, olefinic-CH3), 1.40–1.10 (1H, m), 1.14 (3H, s, tert-CH3), 0.87 (3H, d, J ¼ 5:4 Hz, sec-CH3). 13
C
NMR (75 MHz, CDCl3þCCl4): d 212.6 (C, C@O), 146.1 (C, C@CH2), 131.5 (CH), 129.1 (CH), 112.7 (CH2, C@CH2) 53.6 (CH), 52.7 (C, C-8), 48.8
(CH), 42.7 (CH2), 34.8 (CH), 33.6 (2 C, CH2), 29.0 (CH2), 27.6 (CH2), 21.0 (CH3), 18.2 (CH3), 17.2 (CH3). Anal. Calcd for C17H26O: C, 82.87; H,
23
10.64. Found: C, 82.47; H, 10.64. For 12a: ½aꢀ þ135.4 (c 2.6, CHCl3). IR (neat): mmax/cmꢁ1 1665, 1605. 1H NMR (300 MHz, CDCl3þCCl4): d 5.85–
D
5.65 (2H, m, H-3 and 4), 5.02 (1H, br s) and 4.87 (1H, s) [C@CH2], 2.86 (1H, dd, J ¼ 14:7, 3.6 Hz), 2.64–2.46 (3H, m), 2.30–2.16 (4H, m), 2.07 (1H,
dd, J ¼ 13:8, 5.4 Hz), 2.00–1.85 (1H, m), 1.84 (3H, s), 1.74 (3H, s) [2 ꢂ olefinic-CH3], 1.58–1.44 (1H, m), 1.09 (3H, s, tert-CH3). 13C NMR (75 MHz,
CDCl3þCCl4): d 197.9 (C, C@O), 164.5 (C, C-8), 144.9 (C, C@CH2), 132.8 (C, C-9), 132.5 (CH), 128.8 (CH), 115.7 (CH2, C@CH2), 47.5 (C), 45.7
(CH), 39.3 (CH2), 34.7 (CH2), 31.5 (CH2), 28.2 (CH2), 27.8 (CH2), 23.0 (CH3), 20.7 (CH3), 11.6 (CH3). HRMS (QTOF): m=z calcd for C17H24ONa
23
D
22
D
(MþNa): 267.1725. Found: 267.1750. For 12b: ½aꢀ þ177.0 (c 1.3, CHCl3). For 13: ½aꢀ )83.3 (c 1.2, CHCl3). IR (neat): mmax/cmꢁ1 1670, 1615. 1H
NMR (300 MHz, CDCl3þCCl4): d 5.77 (1H, t of dd, J ¼ 16:8, 10.2, 6.6 Hz, CH@CH2), 5.19 (1H, s, H-8), 5.02 (1H, d, J ¼ 16:8 Hz) and 4.98 (1 H,
d, J ¼ 10:2 Hz) [CH@CH2], 2.60–2.00 (9H, m), 1.73 (3H, s) and 1.67 (3H, s) [2 ꢂ olefinic-CH3], 1.53 (1H, quintet, J ¼ 7:5 Hz), 1.29–1.25 (1H, m),
1.28 (3H, s, tert-CH3). 13C NMR (75 MHz, CDCl3þCCl4): d 198.1 (C, C@O), 160.1 (C, C-5), 142.3 (C, C-9), 137.7 (CH, CH@CH2), 130.9 (C, C-4),
122.0 (CH, C-8), 115.8 (CH2, CH@CH2), 52.8 (CH, C-1), 48.2 (C, C-6), 43.3 (CH2), 37.8 (CH2), 34.6 (CH2), 31.5 (CH2), 28.1 (CH2), 26.6 (CH3),
23
D
15.2 (CH3), 12.2 (CH3). HRMS (QTOF): m=z calcd for C17H24ONa (MþNa): 267.1725. Found: 267.1723. For 16a: ½aꢀ þ5.8 (c 1.8, CHCl3). IR
(neat): mmax/cmꢁ1 1667, 1644, 1613. 1H NMR (300 MHz, CDCl3þCCl4): d 5.75 (1H, dd, J ¼ 17:1, 10.5 Hz, CH@CH2), 5.41 (1H, s, H-8), 4.98 (1H,
d, J ¼ 10:5 Hz) and 4.96 (1H, d, J ¼ 17:1 Hz) [CH@CH2] 2.75 (1 H, d, J ¼ 14:8 Hz), 2.56 (1H, dd, J ¼ 17:1, 3.6 Hz), 2.38 (1H, dd, J ¼ 17:1,
15.0 Hz), 2.42-2.00 (5H, m), 1.71 (6H, s) [2 ꢂ olefinic-CH3], 1.43 (1H, dd, J ¼ 9:9, 7.5 Hz) 1.05 (6H, s), 1.00 (3H, s) [3 ꢂ tert-CH3]. 13C NMR
(75 MHz, CDCl3þCCl4): d 199.4 (C, C@O), 166.2 (C, C-5), 147.2 (CH, CH@CH2), 140.8 (C, C-9), 130.5 (C, C-4), 123.6 (CH, C-8), 111.6 (CH2,
C@CH2) 52.5 (CH, C-1), 49.6 (C, C-6), 40.8 (CH2), 40.7 (CH2), 37.1 (C, C-3), 36.0 (CH2), 27.0 (CH2), 26.6 (CH3), 26.5 (CH3), 22.2 (CH3), 14.6
23
D
(CH3), 11.5 (CH3). HRMS (QTOF): m=z calcd for C19H28ONa (MþNa): 295.2038. Found: 295.2050. For 16b: ½aꢀ )83.9 (c 1.55, CHCl3). For 19a:
23
Mp: 123–125 °C. ½aꢀ þ41.4 (c 1.4, CHCl3). IR (neat): mmax/cmꢁ1 1665, 1605. 1H NMR (300 MHz, CDCl3þCCl4): d 5.47 (1H, d, J ¼ 11:7 Hz, H-4),
D
5.40 (1H, ddd, J ¼ 11:7, 11.7, 7.2 Hz, H-3), 2.79, 2.63 (2H, 2 ꢂ d, J ¼ 4:8 Hz, O-CH2), 2.71 (1H, dd, J ¼ 15:0, 10.5 Hz), 2.60–2.30 (4H, m), 2.26
(1H, dd, J ¼ 15:0, 6.6 Hz), 1.98 (1H, dd, J ¼ 10:5, 6.6 Hz), 1.75 (3H, s, olefinic-CH3), 1.70–1.60 (1 H, m), 1.62 (1H, dd, J ¼ 10:5, 3.3 Hz), 1.35 (3H,
s), 1.25 (3H, s), 1.13 (3H, s) and 1.05 (3H, s) [4 ꢂ tert-CH3]. 13C NMR (75 MHz, CDCl3þCCl4): d 197.0 (C, C@O), 165.6 (C, C-8), 142.5 (CH, C-4),
132.4 (C, C-9), 126.4 (CH, C-3), 57.2 (C, C-O), 54.2 (CH2, CH2-O), 47.1 (C), 44.5 (CH, C-12), 42.1 (CH2), 36.6 (CH2), 35.7 (CH2), 35.4 (C), 35.3
(CH3), 26.0 (CH2), 25.7 (CH3), 21.5 (CH3), 20.5 (CH3), 11.8 (CH3). HRMS (QTOF): m=z for C19H28O2Na (MþNa), calcd: 311.1987. Found:
23
311.1993. For 19b: ½aꢀ )102.0 (c 1.4, CHCl3). Crystal data for 19a: X-ray data were collected at 293 K on a SMART CCD-BRUKER
D
ꢀ
diffractometer with graphite monochromatic Mo-Ka radiation (k ¼ 0:7107 A). Structure was solved by direct methods (SIR92). Refinement was by
full-matrix least-squares procedures on F 2 using SHELXL-97. The nonhydrogen atoms were refined anisotropically whereas hydrogen atoms were
ꢀ
refined isotropically. C19H28O2, MW ¼ 288.41, colourless crystal, Crystal system: monoclinic, space group: P2(1), cell parameters: a ¼ 8:470 (4) A,
3
b ¼ 10:268 (5) A, c ¼ 10:497 (5) A, b ¼ 112:44° (1), V ¼ 843:89 A , Z ¼ 2, Dc ¼ 1:135 gcmꢁ3, F (0 0 0)¼ 316:0, l ¼ 0:07 mmꢁ1. Total number of l.s.
parameters ¼ 195, R1 ¼ 0.0581 for 1647 Fo > 4r(Fo) and 0.1193 for all 2828 data. WR2 ¼ 0.2328, GOF ¼ 0.748, restrained GOF ¼ 0.748 for all data.
Crystallographic data (without structure factors) have been deposited with the Cambridge Crystallographic Data Centre and the depository
number is CCDC 226177.
ꢀ
ꢀ
ꢀ